,i  #aaf? ,,congress  #a/ ,session  ,h4 
,r4 #dfbi  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,octob] #h1 #bjai,mr4 
,tonko 7= himself & ,mr4 ,gibbs7        
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,en]gy & ,comm]ce1 & 9 
addition to ! ,committee on ,ways &     
,means1 = a p]iod to be subsequ5tly     
det]m9$ by ! ,speak]1 9 ea* case =      
consid]ation ( su* provisions z fall )9 
! jurisdiction ( ! committee conc]n$  ,a
 ,,bill  ,to am5d title ,,xviii ( !     
,social ,security ,act to require !     
,secret>y ( ,heal? & ,human ,s]vices to 
add a new set ( measures to ! #e-/> rat+
 sy/em "u ! ,m$ic>e ,advantage program 9
 ord] to enc\rage increas$ access to    
biosimil> biological products4  #a4     
,%ort title ,?is ,act may be cit$ z !   
,/> ,rat+ = ,biosimil>s ,act4  #b4      
,addition ( new measures bas$ on access 
to biosimil> biological products to !   
#e-/> rat+ sy/em "u m$ic>e advantage    
7a7 ,9 g5]al ,section #ahec7o77#d7 ( !  
,social ,security ,act 7#db ,u4,s4,c4   

#aciew-#bc7o77#d77 is am5d$ by add+ at !
 end ! foll[+ new subp>agraph3  7,e7    
,addition ( new measures bas$ on access 
to biosimil> biological products  7i7 ,9
 g5]al ,= #bjba & subsequ5t ye>s1 !     
,secret>y %all add a new set ( measures 
to ! #e-/> rat+ sy/em bas$ on access to 
biosimil> biological products cov]$ "u  
"p ,b &1 9 ! case ( ,,ma-,,pd plans1 su*
 products t are cov]$ "p ,d drugs4 ,su* 
measures %all assess ! impact a plan's  
b5efit /ructure may h on enrollees'     
utilization ( or ability to access      
biosimil> biological products1 includ+ 9
 comp>ison to ! ref]5ce biological      
product1 & %all include measures1 z     
applicable1 ) respect to ! foll[+3  7,i7
 ,cov]age ,assess+ :e!r a biosimil>     
biological product is on ! plan =mul>y 9
 lieu ( or 9 addition to ! ref]5ce      
biological product4  7,,ii7 ,pref]5c+   
,assess+ ti] placem5t or co/ %>+ = a    
biosimil> biological product relative to
 ! ref]5ce biological product4  7,,iii7 
,utilization managem5t tools ,assess+   

:e!r & h[ utilization managem5t tools   
are us$ ) respect to a biosimil>        
biological product relative to ! ref]5ce
 biological product4  7,,iv7            
,utilization ,assess+ ! p]c5tage (      
enrollees prescrib$ ! biosimil>         
biological product :5 ! ref]5ce         
biological product is also available4   
7ii7 ,def9itions ,9 ?is subp>agraph1 !  
t]ms biosimil> biological product &     
ref]5ce biological product h ! mean+    
giv5 ^? t]ms 9 section #ahdg;,a7c77#f74 
7iii7 ,protect+ pati5t int]e/s ,9       
develop+ su* measures1 ! ,secret>y %all 
ensure t ea* measure develop$ to address
 cov]age1 preferenc+1 or utilization    
managem5t is con/ruct$ su* t pati5ts    
reta9 equal access to appropriate       
!rapeutic options )\t undue adm9i/rative
 burd54  4  7b7 ,cl>ification reg>d+    
application to prescription drug plans  
,to ! ext5t ! ,secret>y ( ,heal? &      
,human ,s]vices applies ! #e-/> rat+    
sy/em "u section #ahec7o77#d7 ( !       
,social ,security ,act 7#db ,u4,s4,c4   

#aciew-#bc7o77#d771 or a simil> sy/em1  
to prescription drug plans "u "p ,d (   
title ,,xviii ( su* ,act1 ! provisions (
 subp>agraph 7,e7 ( su* section1 z add$ 
by subsection 7a7 ( ?is section1 %all   
apply "u ! sy/em ) respect to su* plans 
9 ! same mann] z su* provisions apply to
 ! #e-/> rat+ sy/em "u su* section      
#ahec7o77#d74